Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

Trial Profile

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Nov 2014

At a glance

  • Drugs Budesonide (Primary)
  • Indications IgA nephropathy
  • Focus Therapeutic Use
  • Sponsors Pharmalink AB
  • Most Recent Events

    • 19 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top